Skip to main content

Together we are beating cancer

Donate now

Treatment

Showing 12 out of 1231 results
A microscopic image of a natural killer cell, a type of immune cell important for protecting against myeloma.

Researchers at University College London are investigating whether inherited genes can change how the body responds to smouldering myeloma. Researchers at University College London are investigating whether inherited genes can change how the body responds to smouldering myeloma.

by Elizabeth Kusimo, Tim Gunn | Analysis | 16 September 2026

16 September 2026

Woman waiting in hospital waiting room

Get the latest updates and analysis on NHS cancer waiting times in England, and learn what it means for people affected by cancer Get the latest updates and analysis on NHS cancer waiting times in England, and learn what it means for people affected by cancer

by Sophia Lowes, Momoko Bowles | Analysis | 13 September 2026

13 September 2026

An image of a radiotherapy machine. Its lights are glowing blue.

Based on our research, NHS England will use stereotactic ablative radiotherapy (SABR) to treat many early-stage prostate cancers in five sessions, rather than 20.  Based on our research, NHS England will use stereotactic ablative radiotherapy (SABR) to treat many early-stage prostate cancers in five sessions, rather than 20. 

by Tim Gunn | News | 17 June 2026

17 June 2026

NexTGen team looking at a computer screen in lab

A pioneering trial from Cancer Grand Challenges team NexTGen is testing whether their cutting-edge new therapy can help treat children and young people with solid tumours by harnessing the immune system. A pioneering trial from Cancer Grand Challenges team NexTGen is testing whether their cutting-edge new therapy can help treat children and young people with solid tumours by harnessing the immune system.

by Sophie Wedekind | News | 8 April 2026

8 April 2026

A group of microscopic glioblastoma cells against a black background. The cells are coloured red, with their steroid receptors marked in green.

Our researchers have found that steroids, vital tools for managing brain tumour symptoms, could also make glioblastomas vulnerable to a special diet. Our researchers have found that steroids, vital tools for managing brain tumour symptoms, could also make glioblastomas vulnerable to a special diet.

by Fiona MacLeod, Tim Gunn | Analysis | 20 February 2026

20 February 2026

This entry is part 31 of 38 in the series That Cancer Conversation
%postcontent%
A computer generated microscopic image of purple lung cancer cells with a genetic mutation.
  • Science & Technology
  • Health & Medicine

Our defining research stories of 2025

2025 has been a huge year for research at Cancer Research UK. To celebrate, we've brought together our most defining research stories of the year. 2025 has been a huge year for research at Cancer Research UK. To celebrate, we've brought together our most defining research stories of the year.

by Amal Iman | In depth | 19 December 2025

19 December 2025

2D image of scientist hands with a cancer vaccine vial and needle
  • Health & Medicine
  • Science & Technology

Cancer Vaccines - where are we?

Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever? Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever?

by Sophie Wedekind | In depth | 20 November 2025

20 November 2025

A cluster of different sized pink cells seen through a microscope.

Our researchers discovered that EGFR, a molecule produced by our cells, can fuel cancer growth. This breakthrough led to the development of targeted treatments that attack cancer at its source. Our researchers discovered that EGFR, a molecule produced by our cells, can fuel cancer growth. This breakthrough led to the development of targeted treatments that attack cancer at its source.

by Henry Scowcroft | In depth | 13 November 2025

13 November 2025